logo
ScreenersREIT EarningsREIT SectorsMarketplaceLearn
Logo

Cardiol Therapeutics Inc.

CRDL.TO

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx as a cardioprotecā€¦ read more

Healthcare

Drug Manufacturersā€”Specialty & Generic

4 years

CAD

Exclusive to Premium users

Price

per share adjusted in CAD

$1.83

Price

-1.08%

-$0.02

$1.85

Previous Close

$1.87

Open

Premium

52w Discount
Market Cap

$151.249m

Small

Price/Earnings

-

Premium

3y Avg

Premium

5y Avg

Financials Overview

Key metrics over the past few years

-

EBITDA Margin

-

Net Profit Margin

-

Free Cash Flow Margin
Revenue

$0.00

-

1y CAGR

-

3y CAGR

-

5y CAGR
Earnings

-$35.785m

-

1y CAGR

-

3y CAGR

-

5y CAGR
EPS

-$0.48

-

1y CAGR

-

3y CAGR

-

5y CAGR
Book Value

$17.588m

$25.455m

Assets

$7.867m

Liabilities

$150.660k

Debt
Debt to Assets

0.6%

-

Debt to EBITDA
Free Cash Flow

-$25.322m

-

1y CAGR

-

3y CAGR

-

5y CAGR

Financial Reports

Earnings and other important metrics. Amounts in CAD.
No items found.
ā†‘ TopSummaryPriceFinancials
logo
About usFAQ
All the information presented is collected from official and public documents such as: Quarterly and Annual Reports, 10-K (US), Information Form (Canada), Presentations and the Investor Relations (IR) section of the company's website.
The data displayed by alreits.com is solely for informational purposes, we do not recommend the buying, holding or selling of any of the stocks on the website. If you have no experience in the stock market, please talk to your personal licensed investment advisor before making any decisions.